Anti-HER2-specific 5F7GGC Nb nanobodies that are radioiodinated with131I IB-Mal-D-GEEEK were produced for determining HER2 expression in breast cancer patients before trastuzumab administration. The gene discussed is ERBB2; the disease is breast carcinoma.